CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 32 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% |
| Q1 2021 | $46,323,000 | +2.4% | 49,064,000 | 0.0% | 0.97% | +8.9% |
| Q4 2020 | $45,236,000 | +2.5% | 49,064,000 | 0.0% | 0.89% | -16.8% |
| Q3 2020 | $44,114,000 | +0.2% | 49,064,000 | 0.0% | 1.07% | -16.2% |
| Q2 2020 | $44,037,000 | +1.0% | 49,064,000 | 0.0% | 1.28% | -7.3% |
| Q1 2020 | $43,581,000 | +1.6% | 49,064,000 | 0.0% | 1.38% | +1.0% |
| Q4 2019 | $42,905,000 | +1.5% | 49,064,000 | 0.0% | 1.37% | -20.5% |
| Q3 2019 | $42,262,000 | +165.8% | 49,064,000 | +172.6% | 1.72% | +201.8% |
| Q2 2019 | $15,902,000 | +242.2% | 18,000,000 | +260.0% | 0.57% | +220.8% |
| Q1 2019 | $4,647,000 | -72.6% | 5,000,000 | -69.7% | 0.18% | -74.5% |
| Q4 2016 | $16,979,000 | – | 16,500,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |